News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Carlyle Near Deal To Buy Johnson & Johnson (JNJ) Diagnostics Unit For Approximately $4 Billion



12/26/2013 9:18:44 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Private equity firm Carlyle Group LP (CG.O) is nearing an agreement to acquire Johnson & Johnson's (JNJ.N) ortho clinical diagnostics unit, four people familiar with the matter said on Monday, in a deal expected to be worth around $4 billion. Carlyle is in exclusive talks with Johnson & Johnson after prevailing over a rival bid from Blackstone Group LP (BX.N) in partnership with healthcare and industrial conglomerate Danaher Corp (DHR.N), the people said, cautioning that negotiations were ongoing and the outcome could change. A deal is expected to be reached within the next two weeks, one of the sources said.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at New York Times
Read at Live Mint
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES